Cases started on MDR-TB treatment in Latvia
Latvia: Cases started on MDR-TB treatment was 11 in 2024. ◆ Volatile
Cases started on MDR-TB treatment in Latvia, 2009–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for cases started on mdr-tb treatment in Latvia is 11, measured in 2024.
The figure is down 42.1% on the previous year and down 84.3% over ten years.
Over the whole period, cases started on mdr-tb treatment in Latvia peaked at 398 in 2019 and was at its lowest, 10, in 2021.
Latvia ranks 119th of 193 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Cases started on MDR-TB treatment in Latvia, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 124 | — |
| 2010 | 87 | -29.8% |
| 2011 | 103 | +18.4% |
| 2012 | 110 | +6.8% |
| 2013 | 79 | -28.2% |
| 2014 | 70 | -11.4% |
| 2015 | 63 | -10.0% |
| 2016 | 39 | -38.1% |
| 2017 | 38 | -2.6% |
| 2018 | 41 | +7.9% |
| 2019 | 398 | +870.7% |
| 2021 | 10 | -97.5% |
| 2022 | 19 | +90.0% |
| 2024 | 11 | -42.1% |
Latvia compared with similar countries
- Latvia's 11 is above the median for high income countries, which is 7, 1.6× the median. (62 countries reporting)
- Latvia's 11 is below the median for Europe & Central Asia, which is 12.5, 88% of the median. (48 countries reporting)
Biggest year-on-year movements
Years where Cases started on MDR-TB treatment in Latvia changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2019 | +870.7% | 41 | 398 |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 124 | 124 | 124 | 1 |
| 2010s | 102.8 | 38 | 398 | 10 |
| 2020s | 13.33 | 10 | 19 | 3 |
Countries ranked near Latvia
More health data for Latvia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3876 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,593 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -6.17 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0202 units per person (2025)
- Population ages 00-04, male, annual growth rate -6.02 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cases started on mdr-tb treatment in Latvia?
- Cases started on mdr-tb treatment in Latvia was 11 in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest cases started on mdr-tb treatment recorded in Latvia?
- The highest recorded value was 398 in 2019.
- What is the lowest cases started on mdr-tb treatment recorded in Latvia?
- The lowest recorded value was 10 in 2021.
- How does Latvia rank for cases started on mdr-tb treatment?
- Latvia ranks 119th out of 193 countries with data for 2024.
- Is cases started on mdr-tb treatment rising or falling in Latvia?
- Over the last ten years it is down 84.3%. The long-run trend across the full record is volatile.
- Where does this Latvia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Cases started on MDR-TB treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 14 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).